大系列透明变性梁状肿瘤:细针穿刺细胞形态学与辅助技术分析
该研究分析了26例组织学确诊的透明变性梁状肿瘤(HTT),其中18例有细针穿刺细胞学(LBC制片)。细胞学诊断多落入Bethesda不确定类别(83.3%),89%病例免疫组化panel阴性,且100%为BRAFV600E野生型,支持HTT为良性肿瘤。
要点
- HTT细胞学常被误判为乳头状癌或髓样癌,本系列83.3%为不确定类别。
- 免疫组化HBME-1和galectin-3阴性及BRAFV600E野生型支持良性诊断。
- 细胞学诊断不确定时,应结合辅助检测避免不必要的甲状腺全切。
核心结论
- 多数HTT(83.3%)细胞学诊断为Bethesda不确定类别,形态学特征难以 conclusive 诊断。
- 辅助检测结果支持HTT为良性肿瘤。
研究设计与样本
- 在LBC和组织标本上行HBME-1、galectin-3免疫细胞化学及BRAFV600E突变检测。
主要发现
- 18例细胞学病变大小5-45 mm。
- 细胞学诊断:良性倾向甲状腺肿1例(5.5%),意义不明的异型性4例(22.2%),滤泡性肿瘤6例(33.3%),可疑恶性倾向乳头状癌5例(28%),恶性2例(11%)。
- 89%的HTT免疫panel阴性一致,100%为BRAFV600E野生型。
关键数值与推荐
- 细胞学Bethesda不确定类别占83.3%。
- 免疫panel阴性一致率89%,BRAFV600E野生型100%。
临床怎么用
- 对细胞学不确定的甲状腺结节,若免疫组化HBME-1和galectin-3阴性且BRAFV600E野生型,可提示HTT可能,避免过度治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyalinizing trabecular tumors (HTTs) are rare, essentially benign, follicular cell-derived thyroid neoplasms characterized by a trabecular growth pattern and nuclear pseudoinclusions. Their cytological findings are misleading, because these tumors are often misinterpreted on fine needle aspirate cytology as malignant lesions, such as papillary thyroid cancer and/or medullary thyroid cancer, leading to unnecessary total thyroidectomy. The aim of this study was to analyze the cytomorphological features and application of ancillary techniques in a series of HTTs. METHODS: Of 26 histological cases of HTT collected from September 2001 to December 2018, 18 cases had concomitant cytopathology. Cytological cases were processed with liquid-based cytology (LBC). Immunocytochemistry for HBME-1 and galectine-3 as well as molecular testing for BRAFV600E mutation were performed on both LBC and histological specimens. RESULTS: The 18 lesions with fine needle aspirate cytology ranged in size from 5 to 45 mm. Cytological diagnoses included: 1 benign lesion favoring goiter (5.5%), 4 atypia of undetermined significance (22.2%), 6 follicular neoplasms (33.3%), 5 suspicious for malignancy favoring papillary thyroid cancer (28%), and 2 malignant (11%). Hence, 89% HTT had a negative concordant immunopanel, and they were 100% wild-type BRAFV600E . CONCLUSION: The majority of our HTTs (83.3%) were diagnosed in the indeterminate Bethesda categories, suggesting that their cytomorphological features pose issues for reaching a conclusive cytological diagnosis. The ancillary test results in our series support the fact that HTT is a benign neoplasm.
引用
- Dell'Aquila M, Gravina C, Cocomazzi A, et al. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration. Cancer Cytopathol. 2019. PMID: 31135104. doi:10.1002/cncy.22139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。